Corrigendum: Adenovirus-mediated overexpression of BMP-9 inhibits human osteosarcoma cell growth and migration through downregulation of the PI3K/AKT pathway (International Journal of Oncology (2012) 41 (1809-1819) DOI: 10.3892/ijo.2012.1617);Adenovirus-mediated overexpression of BMP-9 inhibits human osteosarcoma cell growth and migration through downregulation of the PI3K/AKT pathway

International Journal of Oncology

Volumn 41, Issue 5, 2012, Pages 1809-1819

  Li, Bo ^a   Yang, Yuehua ^a   Jiang, Shengdan ^a   Ni, Binbin ^a   Chen, Ke ^a   Jiang, Leisheng ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

AKT; BMP 9; Growth; Migration; Osteosarcoma; PI3K

Indexed keywords

BONE MORPHOGENETIC PROTEIN 9; FLUORESCEIN ISOTHIOCYANATE; GELATINASE B; HOE 33342; KI 67 ANTIGEN; LIPOCORTIN 5; MESSENGER RNA; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHOINOSITIDE 3 KINASE P85ALPHA; PROTEIN KINASE B; RECOMBINANT BONE MORPHOGENETIC PROTEIN 9; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG;

ADENOVIRUS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CANCER GROWTH; CELL ASSAY; CELL GROWTH; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE OVEREXPRESSION; IN VITRO STUDY; IN VIVO STUDY; MIGRATION INHIBITION; MOUSE; NONHUMAN; NUDE MOUSE; OSTEOSARCOMA; OSTEOSARCOMA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TUMOR VOLUME; VIRAL GENE DELIVERY SYSTEM; WESTERN BLOTTING; WOUND HEALING;

EID: 84867788302     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2016.3714     Document Type: Erratum

References (38)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E and Forman D: Global cancer statistics. CA Cancer J Clin 61: 69-90, 2011.
2. Kim M and Choe S: BMPs and their clinical potentials. BMB Rep 44: 619-634, 2011.
3. Boon MR, van der Horst G, van der Pluijm G, et al: Bone morphogenetic protein 7: a broad-spectrum growth factor with multiple target therapeutic potency. Cytokine Growth Factor Rev 22: 221-229, 2011.
4. Gobbi G, Sangiorgi L, Lenzi L, et al: Seven BMPs and all their receptors are simultaneously expressed in osteosarcoma cells. Int J Oncol 20: 143-147, 2002.
5. Yoshikawa H, Nakase T, Myoui A and Ueda T: Bone morphogenetic proteins in bone tumors. J Orthop Sci 9: 334-340, 2004. (Pubitemid 38802096)
6. Sulzbacher I, Birner P, Trieb K, Pichlbauer E and Lang S: The expression of bone morphogenetic proteins in osteosarcoma and its relevance as a prognostic parameter. J Clin Pathol 55: 381-385, 2002. (Pubitemid 34494179)
7. Sotobori T, Ueda T, Myoui A, et al: Bone morphogenetic protein-2 promotes the haptotactic migration of murine osteoblastic and osteosarcoma cells by enhancing incorporation of integrin beta1 into lipid rafts. Exp Cell Res 312: 3927-3938, 2006. (Pubitemid 44633892)
8. Weiss KR, Cooper GM, Jadlowiec JA, McGough RL III and Huard J: VEGF and BMP expression in mouse osteosarcoma cells. Clin Orthop Relat Res 450: 111-117, 2006. (Pubitemid 44342124)
9. Song JJ, Celeste AJ, Kong FM, Jirtle RL, Rosen V and Thies RS: Bone morphogenetic protein-9 binds to liver cells and stimulates proliferation. Endocrinology 136: 4293-4297, 1995.
10. Ploemacher RE, Engels LJ, Mayer AE, Thies S and Neben S: Bone morphogenetic protein 9 is a potent synergistic factor for murine hemopoietic progenitor cell generation and colony formation in serum-free cultures. Leukemia 13: 428-437, 1999. (Pubitemid 29108082)
11. Helm GA, Alden TD, Beres EJ, et al: Use of bone morphogenetic protein-9 gene therapy to induce spinal arthrodesis in the rodent. J Neurosurg 92: 191-196, 2000. (Pubitemid 30207415)
12. López-Coviella I, Berse B, Krauss R, Thies RS and Blusztajn JK: Induction and maintenance of the neuronal cholinergic phenotype in the central nervous system by BMP-9. Science 289: 313-316, 2000. (Pubitemid 30469912)
13. Chen C, Grzegorzewski KJ, Barash S, et al: An integrated functional genomics screening program reveals a role for BMP-9 in glucose homeostasis. Nat Biotechnol 21: 294-301, 2003. (Pubitemid 36314814)
14. Truksa J, Peng H, Lee P and Beutler E: Bone morphogenetic proteins 2, 4, and 9 stimulate murine hepcidin 1 expression independently of Hfe, transferrin receptor 2 (Tfr2), and IL-6. Proc Natl Acad Sci USA 103: 10289-10293, 2006. (Pubitemid 44051159)
15. David L, Mallet C, Mazerbourg S, Feige JJ and Bailly S: Identification of BMP9 and BMP10 as functional activators of the orphan activin receptor-like kinase 1 (ALK1) in endothelial cells. Blood 109: 1953-1961, 2007. (Pubitemid 46348192)
16. Brown, MA, Zhao Q, Baker KA, et al: Crystal structure of BMP-9 and functional interactions with pro-region and receptors. J Biol Chem 280: 25111-25118, 2005. (Pubitemid 40934603)
17. Scharpfenecker M, van Dinther M, Liu Z, et al: BMP-9 signals via ALK1 and inhibits hFGF-induced endothelial cell proliferation and VEGF-stimulated angiogenesis. J Cell Sci 120: 964-972, 2007. (Pubitemid 46638511)
18. Upton PD, Davies RJ, Trembath RC and Morrell NW: Bone morphogenetic protein (BMP) and activin type II receptors balance BMP9 signals mediated by activin receptor-like kinase-1 in human pulmonary artery endothelial cells. J Biol Chem 284: 15794-15804, 2009.
19. Ye L, Kynaston H and Jiang WG: Bone morphogenetic protein-9 induces apoptosis in prostate cancer cells, the role of prostate apoptosis response-4. Mol Cancer Res 6: 1594-1606, 2008.
20. Hanahan D and Weinberg RA: Hallmarks of cancer: the next generation. Cell 144: 646-674, 2011.
21. Yang LJ and Jin Y: Immunohistochemical observation of bone morphogenetic protein in normal and abnormal conditions. Clin Orthop Relat Res 257: 249-256, 1990.
22. Laiitnen M, Jortikka L, Halttunen T, et al: Measurement of total and local bone morphogenetic protein concentration in bone tumours. Int Orthop 21:188-193, 1997. (Pubitemid 27371123)
23. Yoshikawa H, Shimizu K, Nakase T and Takaoka K: Periosteal sunburst speculation in osteosarcoma. A possible role for bone morphogenetic protein. Clin Orthop Relat Res 308: 213-219, 1994. (Pubitemid 24349331)
24. Yoshikawa H, Retting WJ, Lane JM, et al: Immunohistochemical detection of bone morphogenetic protein in bone and soft-tissue sarcomas. Cancer 74: 842-847, 1994. (Pubitemid 24237463)
25. Yoshikawa H, Retting WJ, Takaoka K, et al: Expression of bone morphogenetic proteins in human osteosarcoma. Immunohistochemical detection with monoclonal antibody. Cancer 73: 85-91, 1994. (Pubitemid 24012726)
26. Bidart M, Ricard N, Levet S, et al: BMP9 is produced by hepatocytes and circulates mainly in an active mature form complexed to its prodomain. Cell Mol Life Sci 69: 313-324, 2012.
27. Suzuki Y, Ohga N, Morishita Y, et al: BMP-9 induces proliferation of multiple types of endothelial cells in vitro and in vivo. J Cell Sci 123: 1684-1692, 2010.
28. Castonguay R, Werner ED, Matthews RG, et al: Soluble endoglin specifically binds bone morphogenetic proteins 9 and 10 via its orphan domain, inhibits blood vessel formation, and suppresses tumor growth. J Biol Chem 286: 30034-30046, 2011.
29. Herrera B, van Dinther M, Ten Dijke P and Inman GJ: Autocrine bone morphogenetic protein-9 signals through activin receptor-like kinase-2/Smad1/Smad4 to promote ovarian cancer cell proliferation. Cancer Res 69: 9254-9262, 2009.
30. Hotfilder M, Sondermann P, Senss A, et al: PI3K/AKT is involved in mediating survival signals that rescue Ewing tumor cells from fibroblast growth factor 2-induced cell death. Br J Cancer 92: 705-710, 2005. (Pubitemid 40460607)
31. Tsubaki M, Yamazoe Y, Yanae M, et al: Blockade of the Ras/MEK/ERK and Ras/PI3K/Akt pathways by statins reduces the expression of bFGF, HGF, and TGF-β as angiogenic factors in mouse osteosarcoma. Cytokine 54: 100-107, 2011.
32. Jin S, Pang RP, Shen JN, et al: Grifolin induces apoptosis via inhibition of PI3K/AKT signaling pathway in human osteosarcoma cells. Apoptosis 12: 1317-1326, 2007. (Pubitemid 46890391)
33. Liu B, Shi ZL, Feng J and Tao HM: Celecoxib, a cyclooxygenase-2 inhibitor, induces apoptosis in human osteosarcoma cell line MG-63 via down-regulation of PI3K/Akt. Cell Biol Int 32: 494-501, 2008.
34. Wu Z, Min L, Chen D, et al: Overexpression of BMI-1 promotes cell growth and resistance to cisplatin treatment in osteosarcoma. PLoS One 6: e14648, 2011.
35. Hernández-Rodríguez NA, Correa E, Sotelo R, et al: Ki-67: a proliferative marker that may predict pulmonary metastases and mortality of primary osteosarcoma. Cancer Detect Prev 25: 210-215, 2001.
36. Loukopoulos P, O'Brien T, Ghoddusi M, Mungall BA and Robinson WF: Characterization of three novel canine osteosarcoma cell lines producing high levels of matrix metalloproteinases. Res Vet Sci 77: 131-141, 2004. (Pubitemid 38950327)
37. Cawston TE and Wilson AJ: Understanding the role of tissue degrading enzymes and their inhibitors in development and disease. Best Pract Res Clin Rheumatol 20: 983-1002, 2006. (Pubitemid 44356460)
38. Fu Y, Zhang Q, Kang C, et al: Inhibitory effects of adenovirus mediated COX-2, Akt1 and PIK3R1 shRNA on the growth of malignant tumor cells in vitro and in vivo. Int J Oncol 35: 583-591, 2009.